At KweHealth, we explore the translational potential of perinatal tissues—including placental membrane, amniotic fluid, umbilical cord (Wharton's Jelly, cord blood), and placental disc—as raw materials for exosomes, secretome and cellular regenerative therapies. These tissues, readily sourced from healthy donors post-birth and typically discarded as medical waste, possess unique biochemical and structural properties that support tissue repair, reduce inflammation, promote angiogenesis, and modulate immune responses. Our research is dedicated to mapping these unique properties to therapeutic applications, creating a clear roadmap for selecting the right biomaterials to achieve specific clinical goals.